UBS raised the firm’s price target on Vistra to $115 from $110 and keeps a Buy rating on the shares. The stock has pulled back, but UBS does not believe the supply response eliminates the bull thesis, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VST: